OBO ID: CHEBI:28001

Term Name:	vancomycin		Search Ontology:
Synonyms:	(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21 (2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):C(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl- (3S,6R,7R,11R,23S,26S,30aS,36R,38aR)-44-[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-(N-methy Vancocin vancomicin vancomicina vancomycin vancomycine vancomycinum
Definition:	A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.
References:	Beilstein:3132 CAS:1404-90-6 DrugBank:DB00512 Drug_Central:2807 KEGG:C06689 KEGG:D00212 KNApSAcK:C00016052 MetaCyc:CPD-12245 PDBeChem:VAN PMID:11028184 PMID:11408222 PMID:11688538 PMID:11864951 PMID:11886013 PMID:11980329 PMID:12019070 PMID:12541895 PMID:12852813 PMID:13370625 PMID:13521912 PMID:14605050 PMID:14702667 PMID:15047516 PMID:15081082 PMID:15465645 PMID:15590714 PMID:15792257 PMID:16183423 PMID:16184232 PMID:16420976 PMID:16596002 PMID:16720708 PMID:17027219 PMID:17184835 PMID:17299012 PMID:17594206 PMID:18030187 PMID:18159039 PMID:18162343 PMID:18260149 PMID:18361944 PMID:18462092 PMID:18582342 PMID:18817166 PMID:18983037 PMID:19107100 PMID:19830166 PMID:20956604 PMID:21109901 PMID:21458937 PMID:21466775 PMID:21664803 PMID:21719238 PMID:21951032 PMID:22011388 PMID:22015328 PMID:22027450 PMID:22124537 Patent:US3067099 Reaxys:3132 Wikipedia:Vancomycin
Ontology:	ChEBI  ( EBI )